Use of medicare data to identify coronary heart disease outcomes in the women's health initiative

Mark A. Hlatky, Roberta M. Ray, Dale R. Burwen, Karen L. Margolis, Karen Johnson, Anna Kucharska-Newton, Joann E. Manson, Jennifer G. Robinson, Monika M. Safford, Matthew Allison, Themistocles L. Assimes, Anthony A. Bavry, Jeffrey Berger, Rhonda M. Cooper-DeHoff, Susan R. Heckbert, Wenjun Li, Simin Liu, Lisa W. Martin, Marco V. Perez, Hilary A. Tindle & 2 others Wolfgang C. Winkelmayer, Marcia L. Stefanick

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background-Data collected as part of routine clinical practice could be used to detect cardiovascular outcomes in pragmatic clinical trials or clinical registry studies. The reliability of claims data for documenting outcomes is unknown. Methods and Results-We linked records of Women's Health Initiative (WHI) participants aged ≥65 years to Medicare claims data and compared hospitalizations that had diagnosis codes for acute myocardial infarction or coronary revascularization with WHI outcomes adjudicated by study physicians. We then compared the hazard ratios for active versus placebo hormone therapy based solely on WHI-adjudicated events with corresponding hazard ratios based solely on claims data for the same hormone trial participants. Agreement between WHI-adjudicated outcomes and Medicare claims was good for the diagnosis of myocardial infarction (κ, 0.71-0.74) and excellent for coronary revascularization (κ, 0.88-0.91). The hormone:placebo hazard ratio for clinical myocardial infarction was 1.31 (95% confidence interval, 1.03-1.67) based on WHI outcomes and 1.29 (95% confidence interval, 1.00-1.68) based on Medicare data. The hazard ratio for coronary revascularization was 1.09 (95% confidence interval, 0.88-1.35) based on WHI outcomes and 1.10 (95% confidence interval, 0.89-1.35) based on Medicare data. The differences between hazard ratios derived from WHI and Medicare data were not significant in 1000 bootstrap replications. Conclusions-Medicare claims may provide useful data on coronary heart disease outcomes among patients aged =65 years in clinical research studies.

Original languageEnglish (US)
Pages (from-to)157-162
Number of pages6
JournalCirculation: Cardiovascular Quality and Outcomes
Volume7
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Women's Health
Medicare
Coronary Disease
Confidence Intervals
Myocardial Infarction
Hormones
Pragmatic Clinical Trials
Placebos
Registries
Hospitalization
Outcome Assessment (Health Care)
Physicians
Research

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Use of medicare data to identify coronary heart disease outcomes in the women's health initiative. / Hlatky, Mark A.; Ray, Roberta M.; Burwen, Dale R.; Margolis, Karen L.; Johnson, Karen; Kucharska-Newton, Anna; Manson, Joann E.; Robinson, Jennifer G.; Safford, Monika M.; Allison, Matthew; Assimes, Themistocles L.; Bavry, Anthony A.; Berger, Jeffrey; Cooper-DeHoff, Rhonda M.; Heckbert, Susan R.; Li, Wenjun; Liu, Simin; Martin, Lisa W.; Perez, Marco V.; Tindle, Hilary A.; Winkelmayer, Wolfgang C.; Stefanick, Marcia L.

In: Circulation: Cardiovascular Quality and Outcomes, Vol. 7, No. 1, 01.01.2014, p. 157-162.

Research output: Contribution to journalArticle

Hlatky, MA, Ray, RM, Burwen, DR, Margolis, KL, Johnson, K, Kucharska-Newton, A, Manson, JE, Robinson, JG, Safford, MM, Allison, M, Assimes, TL, Bavry, AA, Berger, J, Cooper-DeHoff, RM, Heckbert, SR, Li, W, Liu, S, Martin, LW, Perez, MV, Tindle, HA, Winkelmayer, WC & Stefanick, ML 2014, 'Use of medicare data to identify coronary heart disease outcomes in the women's health initiative', Circulation: Cardiovascular Quality and Outcomes, vol. 7, no. 1, pp. 157-162. https://doi.org/10.1161/CIRCOUTCOMES.113.000373
Hlatky, Mark A. ; Ray, Roberta M. ; Burwen, Dale R. ; Margolis, Karen L. ; Johnson, Karen ; Kucharska-Newton, Anna ; Manson, Joann E. ; Robinson, Jennifer G. ; Safford, Monika M. ; Allison, Matthew ; Assimes, Themistocles L. ; Bavry, Anthony A. ; Berger, Jeffrey ; Cooper-DeHoff, Rhonda M. ; Heckbert, Susan R. ; Li, Wenjun ; Liu, Simin ; Martin, Lisa W. ; Perez, Marco V. ; Tindle, Hilary A. ; Winkelmayer, Wolfgang C. ; Stefanick, Marcia L. / Use of medicare data to identify coronary heart disease outcomes in the women's health initiative. In: Circulation: Cardiovascular Quality and Outcomes. 2014 ; Vol. 7, No. 1. pp. 157-162.
@article{163c48ec962247529e3a1b8e3a56414d,
title = "Use of medicare data to identify coronary heart disease outcomes in the women's health initiative",
abstract = "Background-Data collected as part of routine clinical practice could be used to detect cardiovascular outcomes in pragmatic clinical trials or clinical registry studies. The reliability of claims data for documenting outcomes is unknown. Methods and Results-We linked records of Women's Health Initiative (WHI) participants aged ≥65 years to Medicare claims data and compared hospitalizations that had diagnosis codes for acute myocardial infarction or coronary revascularization with WHI outcomes adjudicated by study physicians. We then compared the hazard ratios for active versus placebo hormone therapy based solely on WHI-adjudicated events with corresponding hazard ratios based solely on claims data for the same hormone trial participants. Agreement between WHI-adjudicated outcomes and Medicare claims was good for the diagnosis of myocardial infarction (κ, 0.71-0.74) and excellent for coronary revascularization (κ, 0.88-0.91). The hormone:placebo hazard ratio for clinical myocardial infarction was 1.31 (95{\%} confidence interval, 1.03-1.67) based on WHI outcomes and 1.29 (95{\%} confidence interval, 1.00-1.68) based on Medicare data. The hazard ratio for coronary revascularization was 1.09 (95{\%} confidence interval, 0.88-1.35) based on WHI outcomes and 1.10 (95{\%} confidence interval, 0.89-1.35) based on Medicare data. The differences between hazard ratios derived from WHI and Medicare data were not significant in 1000 bootstrap replications. Conclusions-Medicare claims may provide useful data on coronary heart disease outcomes among patients aged =65 years in clinical research studies.",
author = "Hlatky, {Mark A.} and Ray, {Roberta M.} and Burwen, {Dale R.} and Margolis, {Karen L.} and Karen Johnson and Anna Kucharska-Newton and Manson, {Joann E.} and Robinson, {Jennifer G.} and Safford, {Monika M.} and Matthew Allison and Assimes, {Themistocles L.} and Bavry, {Anthony A.} and Jeffrey Berger and Cooper-DeHoff, {Rhonda M.} and Heckbert, {Susan R.} and Wenjun Li and Simin Liu and Martin, {Lisa W.} and Perez, {Marco V.} and Tindle, {Hilary A.} and Winkelmayer, {Wolfgang C.} and Stefanick, {Marcia L.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1161/CIRCOUTCOMES.113.000373",
language = "English (US)",
volume = "7",
pages = "157--162",
journal = "Circulation: Cardiovascular Quality and Outcomes",
issn = "1941-7713",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Use of medicare data to identify coronary heart disease outcomes in the women's health initiative

AU - Hlatky, Mark A.

AU - Ray, Roberta M.

AU - Burwen, Dale R.

AU - Margolis, Karen L.

AU - Johnson, Karen

AU - Kucharska-Newton, Anna

AU - Manson, Joann E.

AU - Robinson, Jennifer G.

AU - Safford, Monika M.

AU - Allison, Matthew

AU - Assimes, Themistocles L.

AU - Bavry, Anthony A.

AU - Berger, Jeffrey

AU - Cooper-DeHoff, Rhonda M.

AU - Heckbert, Susan R.

AU - Li, Wenjun

AU - Liu, Simin

AU - Martin, Lisa W.

AU - Perez, Marco V.

AU - Tindle, Hilary A.

AU - Winkelmayer, Wolfgang C.

AU - Stefanick, Marcia L.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background-Data collected as part of routine clinical practice could be used to detect cardiovascular outcomes in pragmatic clinical trials or clinical registry studies. The reliability of claims data for documenting outcomes is unknown. Methods and Results-We linked records of Women's Health Initiative (WHI) participants aged ≥65 years to Medicare claims data and compared hospitalizations that had diagnosis codes for acute myocardial infarction or coronary revascularization with WHI outcomes adjudicated by study physicians. We then compared the hazard ratios for active versus placebo hormone therapy based solely on WHI-adjudicated events with corresponding hazard ratios based solely on claims data for the same hormone trial participants. Agreement between WHI-adjudicated outcomes and Medicare claims was good for the diagnosis of myocardial infarction (κ, 0.71-0.74) and excellent for coronary revascularization (κ, 0.88-0.91). The hormone:placebo hazard ratio for clinical myocardial infarction was 1.31 (95% confidence interval, 1.03-1.67) based on WHI outcomes and 1.29 (95% confidence interval, 1.00-1.68) based on Medicare data. The hazard ratio for coronary revascularization was 1.09 (95% confidence interval, 0.88-1.35) based on WHI outcomes and 1.10 (95% confidence interval, 0.89-1.35) based on Medicare data. The differences between hazard ratios derived from WHI and Medicare data were not significant in 1000 bootstrap replications. Conclusions-Medicare claims may provide useful data on coronary heart disease outcomes among patients aged =65 years in clinical research studies.

AB - Background-Data collected as part of routine clinical practice could be used to detect cardiovascular outcomes in pragmatic clinical trials or clinical registry studies. The reliability of claims data for documenting outcomes is unknown. Methods and Results-We linked records of Women's Health Initiative (WHI) participants aged ≥65 years to Medicare claims data and compared hospitalizations that had diagnosis codes for acute myocardial infarction or coronary revascularization with WHI outcomes adjudicated by study physicians. We then compared the hazard ratios for active versus placebo hormone therapy based solely on WHI-adjudicated events with corresponding hazard ratios based solely on claims data for the same hormone trial participants. Agreement between WHI-adjudicated outcomes and Medicare claims was good for the diagnosis of myocardial infarction (κ, 0.71-0.74) and excellent for coronary revascularization (κ, 0.88-0.91). The hormone:placebo hazard ratio for clinical myocardial infarction was 1.31 (95% confidence interval, 1.03-1.67) based on WHI outcomes and 1.29 (95% confidence interval, 1.00-1.68) based on Medicare data. The hazard ratio for coronary revascularization was 1.09 (95% confidence interval, 0.88-1.35) based on WHI outcomes and 1.10 (95% confidence interval, 0.89-1.35) based on Medicare data. The differences between hazard ratios derived from WHI and Medicare data were not significant in 1000 bootstrap replications. Conclusions-Medicare claims may provide useful data on coronary heart disease outcomes among patients aged =65 years in clinical research studies.

UR - http://www.scopus.com/inward/record.url?scp=84898730677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898730677&partnerID=8YFLogxK

U2 - 10.1161/CIRCOUTCOMES.113.000373

DO - 10.1161/CIRCOUTCOMES.113.000373

M3 - Article

VL - 7

SP - 157

EP - 162

JO - Circulation: Cardiovascular Quality and Outcomes

JF - Circulation: Cardiovascular Quality and Outcomes

SN - 1941-7713

IS - 1

ER -